KETOVITE

This brand name is authorized in Ireland, Malta

Active ingredients

The drug KETOVITE contains a combination of these active pharmaceutical ingredients (APIs):

1 Vitamin A
UNII 1D1K0N0VVC - VITAMIN A PALMITATE

Vitamin A plays an important role in the visual process. It is isomerised to the 11-cis isomer and subsequently bound to the opsin to form the photoreceptor for vision under subdued light. Vitamin A also participates in the formation and maintenance of the integrity of epithelial tissues and mucous membranes.

Read about Vitamin A
2 Vitamin D2
UNII VS041H42XC - ERGOCALCIFEROL

Vitamin D2 (ergocalciferol) is a fat soluble vitamin. In conjunction with parathyroid hormone and calcitonin, it regulates calcium haemostasis. Ergocalciferol metabolites promote active absorption of calcium and phosphorous by the small intestine, increase rate of excretion and resorption of minerals in bone and promote resorption of minerals in bone and promote resorption of phosphate by renal tubules.

Read about Vitamin D2
3 Choline
UNII 45I14D8O27 - CHOLINE CHLORIDE
Read about Choline
4 Vitamin B12
UNII P6YC3EG204 - CYANOCOBALAMIN

Hydroxocobalamin is used in the treatment and prevention of Vitamin B12 deficiency. For adults, the daily requirement of Vitamin B12 is probably about 1 to 2 micrograms and this amount is present in most normal diets. However, Vitamin B12 only occurs in animal products, not in vegetables, and therefore strict vegetarian or vegan diets that exclude dairy products may provide an inadequate amount, although a deficiency may not be apparent for many years.

Read about Vitamin B12

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A11A Multivitamins, combinations A Alimentary tract and metabolism → A11 Vitamins
Discover more medicines within A11A
A11BA Multivitamins, plain A Alimentary tract and metabolism → A11 Vitamins → A11B Multivitamins, plain
Discover more medicines within A11BA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: IE Health Products Regulatory Authority Identifier(s): 16081
Country: MT Medicines Authority Identifier(s): AA565/02703

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.